|
|
||||||||
Neurological Institute of New York and the Department of Pathology, Columbia Presbyterian Medical Center, New York, New York.
In an effort to determine if there might be an association between Guillain-Barre syndrome and specific antigens of the HLA system, 18 patients with Guillain-Barré syndrome were typed for HLA-A, B, and D antigens. No statistically significant relationship was established by this study.
This article has been cited by other articles:
![]() |
K. Geleijns, G. M.Th. Schreuder, B. C. Jacobs, K. Sintnicolaas, R. van Koningsveld, J. Meulstee, J. D. Laman, and P. A. van Doorn HLA class II alleles are not a general susceptibility factor in Guillain-Barre syndrome Neurology, January 11, 2005; 64(1): 44 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Magira, M. Papaioakim, I. Nachamkin, A. K. Asbury, C. Y. Li, T. W. Ho, J. W. Griffin, G. M. McKhann, and D. S. Monos Differential Distribution of HLA-DQ{beta}/DR{beta} Epitopes in the Two Forms of Guillain-Barre Syndrome, Acute Motor Axonal Neuropathy and Acute Inflammatory Demyelinating Polyneuropathy (AIDP): Identification of DQ{beta} Epitopes Associated with Susceptibility to and Protection from AIDP J. Immunol., March 15, 2003; 170(6): 3074 - 3080. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Prendergast and A. P. Moran Review: Lipopolysaccharides in the development of the Guillain-Barre syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies Innate Immunity, October 1, 2000; 6(5): 341 - 359. [Abstract] [PDF] |
||||
![]() |
I. Nachamkin, B. M. Allos, and T. Ho Campylobacter Species and Guillain-Barre Syndrome Clin. Microbiol. Rev., July 1, 1998; 11(3): 555 - 567. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |